Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Mallinckrodt Hospital Products Inc. recalls Terlivaz (terlipressin for injection)

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.
Products
  • Terlivaz (terlipressin for injection)
Where it was sold

USA nationwide

Nationwide

Units affected
421 vials involved in this recall (2,448 vials distributed)
About this recall
Terlivaz (terlipressin for injection), 0.85mg/vial, Single-Dose Vial, Rx only, Distributed by: Mallinckrodt Hospital Products Inc., Bridgewater, NJ 08807, USA, NDC 43825-200-01